The palmar-plantar erythrodysesthesia (PPE) is the only
clinical adverse event that commonly occurs with capecitabine and/or pegylated
liposomal doxorubicin treatment and it warrants special attention because it is
the most common dose-limiting toxicity. This study is designed to test the
effectiveness of a henna and propolis treatment protocol in the management of
capecitabine and/or pegylated liposomal doxorubicin induced palmar-plantar
erythrodysesthesia.
No comments:
Post a Comment